Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Jelmyto™ (mitomycin) – New orphan drug approval
April 15, 2020 - The FDA announced the approval of UroGen Pharma’s Jelmyto (mitomycin), for the treatment of adult patients with low-grade upper tract urothelial cancer (LG-UTUC).
